Macula densa-targeting gene delivery in vivo using AAV9

Macula densa (MD) cells are key sensory and regulatory cells in the kidney; however, they have been difficult to study because of a lack of cell-specific, user-friendly in vivo research tools. Here we demonstrate the high affinity of wild-type Adeno-Associated Virus serotype 9 (AAV9) for MD cells and the feasibility of AAV9-mediated MD cell-specific genetic manipulations when administered to neonatal mice or after a temporary physiological challenge (low-salt diet) in the adult. A single intraperitoneal injection of low-dose AAV9-GFP given to neonatal mice on postnatal days P2-3 resulted in highly MD-specific and efficient transduction (~85% of all GFP+ cells were Nos1+ MD cells). Proof-of-concept studies used AAV9 to overexpress or knock down biologically relevant genes in MD cells and establish MD gain- and loss-of-function (Gof/Lof) mouse models for initial functional and structural phenotyping using intravital multiphoton microscopy at the single-nephron level and immunofluorescence-based histological analysis. RNAscope confirmed the MD-specific knockdown of Pregnancy-associated plasma protein A2 (Pappa2) expression by AAV9-Pappa2 shRNA treatment in MD-Pappa2Lof mice, and the MD-specific overexpression of Cell communication network 1 (Ccn1) by AAV9-Ccn1 mRNA treatment in MD-Ccn1Gof mice. The mouse phenotypes revealed alterations in classic MD/juxtaglomerular functions (renin control and tubuloglomerular feedback-mediated glomerular hemodynamics) as well as in newly emerging MD cell functions (tissue remodeling). MD-specific genetic manipulations in vivo via AAV9-mediated gene delivery may enable future studies of MD cell functions, including the MD program for endogenous kidney tissue remodeling and regeneration, and support the development of MD cell-targeting gene therapies for kidney diseases.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-16
DOI
https://doi.org/10.64898/2026.11.15.766863
Primary Topic
Virus-based gene therapy research
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Macula densa-targeting gene delivery in vivo using AAV9

János Peti‐Peterdi, Alejandra Becerra Calderon, Georgina Gyarmati, Vadym Buncha et al.
3 links
bioRxiv (Cold Spring Harbor Laboratory)
Virus-based gene therapy research
preprint

Macula densa-targeting gene delivery in vivo using AAV9

János Peti‐Peterdi, Alejandra Becerra Calderon, Georgina Gyarmati, Vadym Buncha, Sachin Deepak, Karam Aboudehen, Audrey Izuhara
preprint en

Abstract

Macula densa (MD) cells are key sensory and regulatory cells in the kidney; however, they have been difficult to study because of a lack of cell-specific, user-friendly in vivo research tools. Here we demonstrate the high affinity of wild-type Adeno-Associated Virus serotype 9 (AAV9) for MD cells and the feasibility of AAV9-mediated MD cell-specific genetic manipulations when administered to neonatal mice or after a temporary physiological challenge (low-salt diet) in the adult. A single intraperitoneal injection of low-dose AAV9-GFP given to neonatal mice on postnatal days P2-3 resulted in highly MD-specific and efficient transduction (~85% of all GFP+ cells were Nos1+ MD cells). Proof-of-concept studies used AAV9 to overexpress or knock down biologically relevant genes in MD cells and establish MD gain- and loss-of-function (Gof/Lof) mouse models for initial functional and structural phenotyping using intravital multiphoton microscopy at the single-nephron level and immunofluorescence-based histological analysis. RNAscope confirmed the MD-specific knockdown of Pregnancy-associated plasma protein A2 (Pappa2) expression by AAV9-Pappa2 shRNA treatment in MD-Pappa2Lof mice, and the MD-specific overexpression of Cell communication network 1 (Ccn1) by AAV9-Ccn1 mRNA treatment in MD-Ccn1Gof mice. The mouse phenotypes revealed alterations in classic MD/juxtaglomerular functions (renin control and tubuloglomerular feedback-mediated glomerular hemodynamics) as well as in newly emerging MD cell functions (tissue remodeling). MD-specific genetic manipulations in vivo via AAV9-mediated gene delivery may enable future studies of MD cell functions, including the MD program for endogenous kidney tissue remodeling and regeneration, and support the development of MD cell-targeting gene therapies for kidney diseases.

bioRxiv (Cold Spring Harbor Laboratory)
University of Southern California (US), Stony Brook University (US)
National Institutes of Health
Good health and well-being
Virus-based gene therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon